Literature DB >> 29530278

A 15 year cohort review of in-hospital pediatric trauma center mortality: A catalyst for injury prevention programming.

Shaylan K Govind1, Neil H Merritt2.   

Abstract

BACKGROUND: The objective of our study was to identify the most common mechanisms of injury leading to death in our pediatric population.
METHODS: A retrospective cohort of fatally injured children 0-17 years old treated at our trauma center during 2000-2015.
RESULTS: The mortality rate in our population was 8% (n = 103). Fifty-five percent were male. The majority (76%) of fatal injuries were blunt. Overall, motor vehicle collisions (MVCs) were the most common mechanism of injury (61%), followed by assault/abuse (9%). Of the deaths caused by MVCs, 37 (59%) were occupants, 11 (17%) were pedestrians, and 6 (10%) were cyclists. In the infant sub-population, assault/abuse was the most common mechanism of injury.
CONCLUSION: MVCs were the leading cause of death in this population. In the infant subpopulation (<1 year), abusive head trauma emerged as the leading mechanism. Injury prevention programming should target abusive head trauma in infants and teen road safety.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Mortality; Pediatrics; Trauma center; Wounds and injuries

Mesh:

Year:  2018        PMID: 29530278     DOI: 10.1016/j.amjsurg.2018.03.001

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

1.  Epidemiology, Patterns of treatment, and Mortality of Pediatric Trauma Patients in Japan.

Authors:  Makoto Aoki; Toshikazu Abe; Daizoh Saitoh; Kiyohiro Oshima
Journal:  Sci Rep       Date:  2019-01-29       Impact factor: 4.379

2.  Health Care Resources and 24,910 Deaths Due to Traffic Accidents: An Ecological Mortality Study in Poland.

Authors:  Agnieszka Genowska; Jacek Jamiołkowski; Krystyna Szafraniec; Justyna Fryc; Andrzej Pająk
Journal:  Int J Environ Res Public Health       Date:  2021-05-22       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.